Microglia and ischemic stroke: A double-edged sword

International Journal of Physiology, Pathophysiology and Pharmacology

Volumn 5, Issue 2, 2013, Pages 73-90

  Patel, Anita R ^a   Ritzel, Rodney ^a   McCullough, Louise D ^a   Liu, Fudong ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

CD45; Chimera; Inflammatory response; Ischemic stroke; Macrophage; Microglia

Indexed keywords

ARGININE; B7 ANTIGEN; CD11B ANTIGEN; CD16 ANTIGEN; CD200 ANTIGEN; CD32 ANTIGEN; CD40 ANTIGEN; CD45 ANTIGEN; CD68 ANTIGEN; CD86 ANTIGEN; CHAPERONIN 60; CHEMOKINE RECEPTOR CX3CR1; DECTIN 1; GANCICLOVIR; IONIZED CALCIUM BINDING ADAPTOR MOLECULE 1; ISOLECTIN B4; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXIREDOXIN; PROTEIN; PURINERGIC RECEPTOR; TOLL LIKE RECEPTOR; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

BRAIN ISCHEMIA; CELL POPULATION; CHIMERA; FLOW CYTOMETRY; HEMISPHERE; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; INFLAMMATION; IRRADIATION; LEUKOCYTE; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROGLIA; MIGRATION; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; PROTEIN EXPRESSION; REVIEW; TRANSGENIC MOUSE; UPREGULATION;

EID: 84878372968     PISSN: None     EISSN: 19448171     Source Type: Journal    
DOI: None     Document Type: Review

References (156)

1. Wang Q, Tang XN and Yenari MA. The inflammatory response in stroke. J Neuroimmunol 2007; 184: 53-68.
2. Iadecola C and Anrather J. The immunology of stroke: from mechanisms to translation. Nat Med 2011; 17: 796-808.
3. Wang X and Feuerstein GZ. The Janus face of inflammation in ischemic brain injury. Acta Neurochir Suppl 2004; 89: 49-54.
4. Wood PL. Microglia as a unique cellular target in the treatment of stroke: potential neurotoxic mediators produced by activated microglia. Neurol Res 1995; 17: 242-248.
5. Neumann H, Kotter MR and Franklin RJ. Debris clearance by microglia: an essential link between degeneration and regeneration. Brain 2009; 132: 288-295.
6. Jin R, Yang G and Li G. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol 2010; 87: 779-789.
7. Chan WY, Kohsaka S and Rezaie P. The origin and cell lineage of microglia: new concepts. Brain Res Rev 2007; 53: 344-354.
8. Gomez Perdiguero E, Schulz C and Geissmann F. Development and homeostasis of "resident" myeloid cells: The case of the microglia. Glia 2013; 61: 112-120.
9. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, Mehler MF, Conway SJ, Ng LG, Stanley ER, Samokhvalov IM and Merad M. Fate mapping analysis reveals that adult mi-croglia derive from primitive macrophages. Science 2010; 330: 841-845.
10. Kissa K and Herbomel P. Blood stem cells emerge from aortic endothelium by a novel type of cell transition. Nature 2010; 464: 112-115.
11. Lichanska AM, Browne CM, Henkel GW, Murphy KM, Ostrowski MC, McKercher SR, Maki RA and Hume DA. Differentiation of the mono-nuclear phagocyte system during mouse em-bryogenesis: the role of transcription factor PU.1. Blood 1999; 94: 127-138.
12. Kierdorf K, Erny D, Goldmann T, Sander V, Schulz C, Perdiguero EG, Wieghofer P, Heinrich A, Riemke P, Holscher C, Muller DN, Luckow B, Brocker T, Debowski K, Fritz G, Opdenakker G, Diefenbach A, Biber K, Heikenwalder M, Geiss-mann F, Rosenbauer F and Prinz M. Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways. Nat Neu-rosci 2013; 46: 273-80.
13. Mizutani M, Pino PA, Saederup N, Charo IF, Ransohoff RM and Cardona AE. The fractal-kine receptor but not CCR2 is present on mi-croglia from embryonic development throughout adulthood. J Immunol 2012; 188: 29-36.
14. Mukouyama Y, Chiba N, Mucenski ML, Satake M, Miyajima A, Hara T and Watanabe T. Hema-topoietic cells in cultures of the murine embryonic aorta-gonad-mesonephros region are induced by c-Myb. Curr Biol 1999; 9: 833-836.
15. Schulz C, Gomez Perdiguero E, Chorro L, Sza-bo-Rogers H, Cagnard N, Kierdorf K, Prinz M, Wu B, Jacobsen SE, Pollard JW, Frampton J, Liu KJ and Geissmann F. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 2012; 336: 86-90.
16. Labastie MC, Cortes F, Romeo PH, Dulac C and Peault B. Molecular identity of hematopoietic precursor cells emerging in the human embryo. Blood 1998; 92: 3624-3635.
17. Erblich B, Zhu L, Etgen AM, Dobrenis K and Pollard JW. Absence of colony stimulation fac-tor-1 receptor results in loss of microglia, disrupted brain development and olfactory deficits. PLoS One 2011; 6: e26317.
18. Ovchinnikov DA. Macrophages in the embryo and beyond: much more than just giant phagocytes. Genesis 2008; 46: 447-462.
19. Tambuyzer BR, Ponsaerts P and Nouwen EJ. Microglia: gatekeepers of central nervous system immunology. J Leukoc Biol 2009; 85: 352-370.
20. Imai Y, Ibata I, Ito D, Ohsawa K and Kohsaka S. A novel gene iba1 in the major histocompatibil-ity complex class III region encoding an EF hand protein expressed in a monocytic lineage. Biochem Biophys Res Commun 1996; 224: 855-862.
21. Ito D, Imai Y, Ohsawa K, Nakajima K, Fukuuchi Y and Kohsaka S. Microglia-specific localisation of a novel calcium binding protein, Iba1. Brain Res Mol Brain Res 1998; 57: 1-9.
22. Ito D, Tanaka K, Suzuki S, Dembo T and Fukuu-chi Y. Enhanced expression of Iba1, ionized calcium-binding adapter molecule 1, after transient focal cerebral ischemia in rat brain. Stroke 2001; 32: 1208-1215.
23. Sedgwick JD, Schwender S, Imrich H, Dorries R, Butcher GW and ter Meulen V. Isolation and direct characterization of resident microglial cells from the normal and infamed central nervous system. Proc Natl Acad Sci U S A 1991; 88: 7438-7442.
24. Ford AL, Goodsall AL, Hickey WF and Sedgwick JD. Normal adult ramified microglia separated from other central nervous system macro-phages by flow cytometric sorting. Phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4+ T cells compared. J Immunol 1995; 154: 4309-4321.
25. Perego C, Fumagalli S and De Simoni MG. Temporal pattern of expression and colocalization of microglia/macrophage phenotype markers following brain ischemic injury in mice. J Neu-roinflammation 2011; 8: 174.
26. Gesuete R, Storini C, Fantin A, Stravalaci M, Zanier ER, Orsini F, Vietsch H, Mannesse ML, Ziere B, Gobbi M and De Simoni MG. Recombi-nant C1 inhibitor in brain ischemic injury. Ann Neurol 2009; 66: 332-342.
27. Guillemin GJ and Brew BJ. Microglia, macro-phages, perivascular macrophages, and peri-cytes: a review of function and identification. J Leukoc Biol 2004; 75: 388-397.
28. Ponomarev ED, Shriver LP, Maresz K and Dittel BN. Microglial cell activation and proliferation precedes the onset of CNS autoimmunity. J Neurosci Res 2005; 81: 374-389.
29. Melief J, Koning N, Schuurman KG, Van De Garde MD, Smolders J, Hoek RM, Van Eijk M, Hamann J and Huitinga I. Phenotyping primary human microglia: tight regulation of LPS responsiveness. Glia 2012; 60: 1506-1517.
30. Hume DA. Applications of myeloid-specific promoters in transgenic mice support in vivo imaging and functional genomics but do not support the concept of distinct macrophage and dendritic cell lineages or roles in immunity. J Leukoc Biol 2011; 89: 525-538.
31. Hirasawa T, Ohsawa K, Imai Y, Ondo Y, Akaza-wa C, Uchino S and Kohsaka S. Visualization of microglia in living tissues using Iba1-EGFP transgenic mice. J Neurosci Res 2005; 81: 357-362.
32. Saederup N, Cardona AE, Croft K, Mizutani M, Cotleur AC, Tsou CL, Ransohoff RM and Charo IF. Selective chemokine receptor usage by central nervous system myeloid cells in CCR2-red fluorescent protein knock-in mice. PLoS One 2010; 5: e13693.
33. Goren I, Allmann N, Yogev N, Schurmann C, Linke A, Holdener M, Waisman A, Pfeilschifter J and Frank S. A transgenic mouse model of inducible macrophage depletion: effects of diphtheria toxin-driven lysozyme M-specific cell lineage ablation on wound inflammatory, angiogenic, and contractive processes. Am J Pathol 2009; 175: 132-147.
34. Gowing G, Vallieres L and Julien JP. Mouse model for ablation of proliferating microglia in acute CNS injuries. Glia 2006; 53: 331-337.
35. Tang X, Zheng Z and Yenari MA. Bone Marrow Chimeras in the Study of Experimental Stroke. Transl. Stroke Res 2012; 3: 341-347.
36. Monje ML, Mizumatsu S, Fike JR and Palmer TD. Irradiation induces neural precursor-cell dysfunction. Nat Med 2002; 8: 955-962.
37. Davoust N, Vuaillat C, Androdias G and Nataf S. From bone marrow to microglia: barriers and avenues. Trends Immunol 2008; 29: 227-234.
38. Mildner A, Schmidt H, Nitsche M, Merkler D, Hanisch UK, Mack M, Heikenwalder M, Bruck W, Priller J and Prinz M. Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nat Neurosci 2007; 10: 1544-1553.
39. Wirenfeldt M, Dissing-Olesen L, Anne Babcock A, Nielsen M, Meldgaard M, Zimmer J, Azcoitia I, Leslie RG, Dagnaes-Hansen F and Finsen B. Population control of resident and immigrant microglia by mitosis and apoptosis. Am J Pathol 2007; 171: 617-631.
40. Li YQ, Chen P, Jain V, Reilly RM and Wong CS. Early radiation-induced endothelial cell loss and blood-spinal cord barrier breakdown in the rat spinal cord. Radiat Res 2004; 161: 143-152.
41. Lambertsen KL, Clausen BH, Babcock AA, Gre-gersen R, Fenger C, Nielsen HH, Haugaard LS, Wirenfeldt M, Nielsen M, Dagnaes-Hansen F, Bluethmann H, Faergeman NJ, Meldgaard M, Deierborg T and Finsen B. Microglia protect neurons against ischemia by synthesis of tumor necrosis factor. J Neurosci 2009; 29: 1319-1330.
42. Linard C, Marquette C, Mathieu J, Pennequin A, Clarencon D and Mathe D. Acute induction of inflammatory cytokine expression after gamma-irradiation in the rat: effect of an NF-kap-paB inhibitor. Int J Radiat Oncol Biol Phys 2004; 58: 427-434.
43. Mizumatsu S, Monje ML, Morhardt DR, Rola R, Palmer TD and Fike JR. Extreme sensitivity of adult neurogenesis to low doses of X-irradia-tion. Cancer Res 2003; 63: 4021-4027.
44. Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, Littman DR, Dustin ML and Gan WB. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 2005; 8: 752-758.
45. Nimmerjahn A, Kirchhoff F and Helmchen F. Resting microglial cells are highly dynamic sur-veillants of brain parenchyma in vivo. Science 2005; 308: 1314-1318.
46. Lawson LJ, Perry VH, Dri P and Gordon S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 1990; 39: 151-170.
47. Carson MJ, Bilousova TV, Puntambekar SS, Melchior B, Doose JM and Ethell IM. A rose by any other name? The potential consequences of microglial heterogeneity during CNS health and disease. Neurotherapeutics 2007; 4: 571-579.
48. Biber K, Neumann H, Inoue K and Boddeke HW. Neuronal 'On' and 'Off' signals control mi-croglia. Trends Neurosci 2007; 30: 596-602.
49. Hoek RM, Ruuls SR, Murphy CA, Wright GJ, Goddard R, Zurawski SM, Blom B, Homola ME, Streit WJ, Brown MH, Barclay AN and Sedgwick JD. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 2000; 290: 1768-1771.
50. Cardona AE, Pioro EP, Sasse ME, Kostenko V, Cardona SM, Dijkstra IM, Huang D, Kidd G, Dombrowski S, Dutta R, Lee JC, Cook DN, Jung S, Lira SA, Littman DR and Ransohoff RM. Control of microglial neurotoxicity by the fractal-kine receptor. Nat Neurosci 2006; 9: 917-924.
51. Fuhrmann M, Bittner T, Jung CK, Burgold S, Page RM, Mitteregger G, Haass C, LaFerla FM, Kretzschmar H and Herms J. Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease. Nat Neurosci 2010; 13: 411-413.
52. Cipriani R, Villa P, Chece G, Lauro C, Paladini A, Micotti E, Perego C, De Simoni MG, Fredholm BB, Eusebi F and Limatola C. CX3CL1 is neuro-protective in permanent focal cerebral ischemia in rodents. J Neurosci 2011; 31: 16327-16335.
53. Koning N, Bo L, Hoek RM and Huitinga I. Down-regulation of macrophage inhibitory molecules in multiple sclerosis lesions. Ann Neurol 2007; 62: 504-514.
54. Barclay AN, Wright GJ, Brooke G and Brown MH. CD200 and membrane protein interactions in the control of myeloid cells. Trends Immunol 2002; 23: 285-290.
55. Koning N, Swaab DF, Hoek RM and Huitinga I. Distribution of the immune inhibitory molecules CD200 and CD200R in the normal central nervous system and multiple sclerosis lesions suggests neuron-glia and glia-glia interactions. J Neuropathol Exp Neurol 2009; 68: 159-167.
56. Webb M and Barclay AN. Localisation of the MRC OX-2 glycoprotein on the surfaces of neurones. J Neurochem 1984; 43: 1061-1067.
57. Barclay AN. The localization of populations of lymphocytes defned by monoclonal antibodies in rat lymphoid tissues. Immunology 1981; 42: 593-600.
58. Chitnis T, Imitola J, Wang Y, Elyaman W, Chawla P, Sharuk M, Raddassi K, Bronson RT and Khoury SJ. Elevated neuronal expression of CD200 protects Wlds mice from inflammation-mediated neurodegeneration. Am J Pathol 2007; 170: 1695-1712.
59. Cox FF, Carney D, Miller AM and Lynch MA. CD200 fusion protein decreases microglial activation in the hippocampus of aged rats. Brain Behav Immun 2012; 26: 789-796.
60. Matsumoto H, Kumon Y, Watanabe H, Ohnishi T, Takahashi H, Imai Y and Tanaka J. Expression of CD200 by macrophage-like cells in ischemic core of rat brain after transient middle cerebral artery occlusion. Neurosci Lett 2007; 418: 44-48.
61. Ludwig A and Weber C. Transmembrane che-mokines: versatile 'special agents' in vascular inflammation. Thromb Haemost 2007; 97: 694-703.
62. Fumagalli S, Perego C, Ortolano F and De Si-moni MG. CX3CR1 defciency induces an early protective inflammatory environment in isch-emic mice. Glia 2013; 61: 827-42.
63. Denes A, Ferenczi S, Halasz J, Kornyei Z and Kovacs KJ. Role of CX3CR1 (fractalkine receptor) in brain damage and inflammation induced by focal cerebral ischemia in mouse. J Cereb Blood Flow Metab 2008; 28: 1707-1721.
64. Soriano SG, Amaravadi LS, Wang YF, Zhou H, Yu GX, Tonra JR, Fairchild-Huntress V, Fang Q, Dunmore JH, Huszar D and Pan Y. Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury. J Neuroim-munol 2002; 125: 59-65.
65. Jiang P, Lagenaur CF and Narayanan V. Integrin-associated protein is a ligand for the P84 neural adhesion molecule. J Biol Chem 1999; 274: 559-562.
66. Fujioka Y, Matozaki T, Noguchi T, Iwamatsu A, Yamao T, Takahashi N, Tsuda M, Takada T and Kasuga M. A novel membrane glycoprotein, SHPS-1, that binds the SH2-domain-contain-ing protein tyrosine phosphatase SHP-2 in response to mitogens and cell adhesion. Mol Cell Biol 1996; 16: 6887-6899.
67. Okazawa H, Motegi S, Ohyama N, Ohnishi H, Tomizawa T, Kaneko Y, Oldenborg PA, Ishikawa O and Matozaki T. Negative regulation of phagocytosis in macrophages by the CD47-SHPS-1 system. J Immunol 2005; 174: 2004-2011.
68. Yamao T, Noguchi T, Takeuchi O, Nishiyama U, Morita H, Hagiwara T, Akahori H, Kato T, Inaga-ki K, Okazawa H, Hayashi Y, Matozaki T, Takeda K, Akira S and Kasuga M. Negative regulation of platelet clearance and of the macrophage phagocytic response by the transmembrane glycoprotein SHPS-1. J Biol Chem 2002; 277: 39833-39839.
69. Jin G, Tsuji K, Xing C, Yang YG, Wang X and Lo EH. CD47 gene knockout protects against transient focal cerebral ischemia in mice. Exp Neu-rol 2009; 217: 165-170.
70. Wang L, Lu Y, Deng S, Zhang Y, Yang L, Guan Y, Matozaki T, Ohnishi H, Jiang H and Li H. SHPS-1 deficiency induces robust neuroprotection against experimental stroke by attenuating oxi-dative stress. J Neurochem 2012; 122: 834-843.
71. Stefano L, Racchetti G, Bianco F, Passini N, Gupta RS, Panina Bordignon P and Meldolesi J. The surface-exposed chaperone, Hsp60, is an agonist of the microglial TREM2 receptor. J Neurochem 2009; 110: 284-294.
72. Piccio L, Buonsanti C, Mariani M, Cella M, Gilfl-lan S, Cross AH, Colonna M and Panina-Bordi-gnon P. Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis. Eur J Immunol 2007; 37: 1290-1301.
73. Takahashi K, Rochford CD and Neumann H. Clearance of apoptotic neurons without infam-mation by microglial triggering receptor expressed on myeloid cells-2. J Exp Med 2005; 201: 647-657.
74. Sieber MW, Jaenisch N, Brehm M, Guenther M, Linnartz-Gerlach B, Neumann H, Witte OW and Frahm C. Attenuated inflammatory response in triggering receptor expressed on myeloid cells 2 (TREM2) knock-out mice following stroke. PLoS One 2013; 8: e52982.
75. Ohsawa K, Irino Y, Nakamura Y, Akazawa C, In-oue K and Kohsaka S. Involvement of P2X4 and P2Y12 receptors in ATP-induced microglial chemotaxis. Glia 2007; 55: 604-616.
76. Haynes SE, Hollopeter G, Yang G, Kurpius D, Dailey ME, Gan WB and Julius D. The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat Neurosci 2006; 9: 1512-1519.
77. Varnum MM and Ikezu T. The classification of microglial activation phenotypes on neurode-generation and regeneration in Alzheimer's disease brain. Arch Immunol Ther Exp (Warsz) 2012; 60: 251-266.
78. Yenari MA, Kauppinen TM and Swanson RA. Microglial activation in stroke: therapeutic targets. Neurotherapeutics 2010; 7: 378-391.
79. Hu X, Li P, Guo Y, Wang H, Leak RK, Chen S, Gao Y and Chen J. Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke 2012; 43: 3063-3070.
80. Ponomarev ED, Veremeyko T and Weiner HL. MicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CNS. Glia 2013; 61: 91-103.
81. Liu HC, Zheng MH, Du YL, Wang L, Kuang F, Qin HY, Zhang BF and Han H. N9 microglial cells polarized by LPS and IL4 show differential responses to secondary environmental stimuli. Cell Immunol 2012; 278: 84-90.
82. Shin WH, Lee DY, Park KW, Kim SU, Yang MS, Joe EH and Jin BK. Microglia expressing inter-leukin-13 undergo cell death and contribute to neuronal survival in vivo. Glia 2004; 46: 142-152.
83. Zhou X, Spittau B and Krieglstein K. TGFbeta signalling plays an important role in IL4-in-duced alternative activation of microglia. J Neuroinflammation 2012; 9: 210.
84. Hanisch UK and Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 2007; 10: 1387-1394.
85. Pal G, Vincze C, Renner E, Wappler EA, Nagy Z, Lovas G and Dobolyi A. Time course, distribution and cell types of induction of transforming growth factor betas following middle cerebral artery occlusion in the rat brain. PLoS One 2012; 7: e46731.
86. Kanazawa H, Ohsawa K, Sasaki Y, Kohsaka S and Imai Y. Macrophage/microglia-specific protein Iba1 enhances membrane ruffing and Rac activation via phospholipase C-gamma -dependent pathway. J Biol Chem 2002; 277: 20026-20032.
87. Colton CA, Abel C, Patchett J, Keri J and Yao J. Lectin staining of cultured CNS microglia. J His-tochem Cytochem 1992; 40: 505-512.
88. Boscia F, Esposito CL, Casamassa A, de Fran-ciscis V, Annunziato L and Cerchia L. The isolectin IB4 binds RET receptor tyrosine ki-nase in microglia. J Neurochem 2013; [Epub ahead of print].
89. Perry VH. A revised view of the central nervous system microenvironment and major histo-compatibility complex class II antigen presentation. J Neuroimmunol 1998; 90: 113-121.
90. Ulvestad E, Williams K, Vedeler C, Antel J, Nyland H, Mork S and Matre R. Reactive microglia in multiple sclerosis lesions have an increased expression of receptors for the Fc part of IgG. J Neurol Sci 1994; 121: 125-131.
91. Vedeler C, Ulvestad E, Grundt I, Conti G, Nyland H, Matre R and Pleasure D. Fc receptor for IgG (FcR) on rat microglia. J Neuroimmunol 1994; 49: 19-24.
92. Wolf SA, Gimsa U, Bechmann I and Nitsch R. Differential expression of costimulatory molecules B7-1 and B7-2 on microglial cells induced by Th1 and Th2 cells in organotypic brain tissue. Glia 2001; 36: 414-420.
93. Becher B and Antel JP. Comparison of pheno-typic and functional properties of immediately ex vivo and cultured human adult microglia. Glia 1996; 18: 1-10.
94. Aloisi F, De Simone R, Columba-Cabezas S, Penna G and Adorini L. Functional maturation of adult mouse resting microglia into an APC is promoted by granulocyte-macrophage colony-stimulating factor and interaction with Th1 cells. J Immunol 2000; 164: 1705-1712.
95. Colton CA, Mott RT, Sharpe H, Xu Q, Van Nos-trand WE and Vitek MP. Expression profles for macrophage alternative activation genes in AD and in mouse models of AD. J Neuroinfamma-tion 2006; 3: 27.
96. Ramprasad MP, Terpstra V, Kondratenko N, Quehenberger O and Steinberg D. Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein. Proc Natl Acad Sci U S A 1996; 93: 14833-14838.
97. Raes G, De Baetselier P, Noel W, Beschin A, Brombacher F and Hassanzadeh Gh G. Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macro-phages. J Leukoc Biol 2002; 71: 597-602.
98. Shah VB, Huang Y, Keshwara R, Ozment-Skel-ton T, Williams DL and Keshvara L. Beta-glu-can activates microglia without inducing cyto-kine production in Dectin-1-dependent manner. J Immunol 2008; 180: 2777-2785.
99. Giraldi-Guimaraes A, de Freitas HT, Coelho Bde P, Macedo-Ramos H, Mendez-Otero R, Caval-cante LA and Baetas-da-Cruz W. Bone marrow mononuclear cells and mannose receptor expression in focal cortical ischemia. Brain Res 2012; 1452: 173-184.
100. Jimenez S, Baglietto-Vargas D, Caballero C, Moreno-Gonzalez I, Torres M, Sanchez-Varo R, Ruano D, Vizuete M, Gutierrez A and Vitorica J. Inflammatory response in the hippocampus of PS1M146L/APP751SL mouse model of Alzheimer's disease: age-dependent switch in the microglial phenotype from alternative to classic. J Neurosci 2008; 28: 11650-11661.
101. Katayama T, Kobayashi H, Okamura T, Yama-saki-Katayama Y, Kibayashi T, Kimura H, Oh-sawa K, Kohsaka S and Minami M. Accumulating microglia phagocytose injured neurons in hippocampal slice cultures: involvement of p38 MAP kinase. PLoS One 2012; 7: e40813.
102. Denes A, Vidyasagar R, Feng J, Narvainen J, McColl BW, Kauppinen RA and Allan SM. Proliferating resident microglia after focal cerebral ischaemia in mice. J Cereb Blood Flow Metab 2007; 27: 1941-1953.
103. Sakanashi Y, Takeya M, Yoshimura T, Feng L, Morioka T and Takahashi K. Kinetics of macro-phage subpopulations and expression of monocyte chemoattractant protein-1 (MCP-1) in bleomycin-induced lung injury of rats studied by a novel monoclonal antibody against rat MCP-1. J Leukoc Biol 1994; 56: 741-750.
104. Kumar AG, Ballantyne CM, Michael LH, Kukiel-ka GL, Youker KA, Lindsey ML, Hawkins HK, Birdsall HH, MacKay CR, LaRosa GJ, Rossen RD, Smith CW and Entman ML. Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium. Circulation 1997; 95: 693-700.
105. Che X, Ye W, Panga L, Wu DC and Yang GY. Monocyte chemoattractant protein-1 expressed in neurons and astrocytes during focal ischemia in mice. Brain Res 2001; 902: 171-17 7.
106. Ceulemans AG, Zgavc T, Kooijman R, Hachimi-Idrissi S, Sarre S and Michotte Y. The dual role of the neuroinflammatory response after isch-emic stroke: modulatory effects of hypothermia. J Neuroinflammation 2010; 7: 74.
107. Dimitrijevic J, Dzirlo K, Bratic M, Hrnjica M, He-bib L, Alajbegovic A, Heco S and Bulic G. [10-year analysis of cerebrovascular accidents at the Neurology Clinic in Sarajevo (before, during and after the war)]. Med Arh 2002; 56: 151-153.
108. del Zoppo GJ, Sharp FR, Heiss WD and Albers GW. Heterogeneity in the penumbra. J Cereb Blood Flow Metab 2011; 31: 1836-1851.
109. Schilling M, Besselmann M, Muller M, Strecker JK, Ringelstein EB and Kiefer R. Predominant phagocytic activity of resident microglia over hematogenous macrophages following transient focal cerebral ischemia: an investigation using green fluorescent protein transgenic bone marrow chimeric mice. Exp Neurol 2005; 196: 290-297.
110. Neher JJ, Neniskyte U, Zhao JW, Bal-Price A, Tolkovsky AM and Brown GC. Inhibition of mi-croglial phagocytosis is sufficient to prevent inflammatory neuronal death. J Immunol 2011; 186: 4973-4983.
111. Franke H, Gunther A, Grosche J, Schmidt R, Rossner S, Reinhardt R, Faber-Zuschratter H, Schneider D and Illes P. P2X7 receptor expression after ischemia in the cerebral cortex of rats. J Neuropathol Exp Neurol 2004; 63: 686-699.
112. Melani A, Turchi D, Vannucchi MG, Cipriani S, Gianfriddo M and Pedata F. ATP extracellular concentrations are increased in the rat stria-tum during in vivo ischemia. Neurochem Int 2005; 47: 442-448.
113. Monif M, Reid CA, Powell KL, Smart ML and Williams DA. The P2X7 receptor drives microg-lial activation and proliferation: a trophic role for P2X7R pore. J Neurosci 2009; 29: 3781-3791.
114. Brough D, Le Feuvre RA, Iwakura Y and Roth-well NJ. Purinergic (P2X7) receptor activation of microglia induces cell death via an interleu-kin-1-independent mechanism. Mol Cell Neu-rosci 2002; 19: 272-280.
115. Ferrari D, Pizzirani C, Adinolf E, Lemoli RM, Curti A, Idzko M, Panther E and Di Virgilio F. The P2X7 receptor: a key player in IL-1 processing and release. J Immunol 2006; 176: 3877-3883.
116. Verderio C and Matteoli M. ATP mediates calcium signaling between astrocytes and microg-lial cells: modulation by IFN-gamma. J Immunol 2001; 166: 6383-6391.
117. Honda S, Sasaki Y, Ohsawa K, Imai Y, Naka-mura Y, Inoue K and Kohsaka S. Extracellular ATP or ADP induce chemotaxis of cultured mi-croglia through Gi/o-coupled P2Y receptors. J Neurosci 2001; 21: 1975-1982.
118. Pellegatti P, Falzoni S, Pinton P, Rizzuto R and Di Virgilio F. A novel recombinant plasma membrane-targeted luciferase reveals a new pathway for ATP secretion. Mol Biol Cell 2005; 16: 3659-3665.
119. Chu K, Yin B, Wang J, Peng G, Liang H, Xu Z, Du Y, Fang M, Xia Q and Luo B. Inhibition of P2X7 receptor ameliorates transient global cerebral ischemia/reperfusion injury via modulating in-fammatory responses in the rat hippocampus. J Neuroinflammation 2012; 9: 69.
120. Melani A, Amadio S, Gianfriddo M, Vannucchi MG, Volonte C, Bernardi G, Pedata F and Sanc-esario G. P2X7 receptor modulation on microg-lial cells and reduction of brain infarct caused by middle cerebral artery occlusion in rat. J Cereb Blood Flow Metab 2006; 26: 974-982.
121. Piccinini AM and Midwood KS. DAMPening in-fammation by modulating TLR signalling. Mediators Infamm 2010; 2010.
122. Ziegler G, Prinz V, Albrecht MW, Harhausen D, Khojasteh U, Nacken W, Endres M, Dirnagl U, Nietfeld W and Trendelenburg G. Mrp-8 and -14 mediate CNS injury in focal cerebral ischemia. Biochim Biophys Acta 2009; 1792: 1198-1204.
123. Chow JC, Young DW, Golenbock DT, Christ WJ and Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduc-tion. J Biol Chem 1999; 274: 10689-10692.
124. Lehnardt S, Lehmann S, Kaul D, Tschimmel K, Hoffmann O, Cho S, Krueger C, Nitsch R, Meisel A and Weber JR. Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia. J Neuroimmunol 2007; 190: 28-33.
125. Bohacek I, Cordeau P, Lalancette-Hebert M, Gorup D, Weng YC, Gajovic S and Kriz J. Tolllike receptor 2 deficiency leads to delayed exacerbation of ischemic injury. J Neuroinfammation 2012; 9: 191.
126. Hyakkoku K, Hamanaka J, Tsuruma K, Shima-zawa M, Tanaka H, Uematsu S, Akira S, Inagaki N, Nagai H and Hara H. Toll-like receptor 4 (TLR4), but not TLR3 or TLR9, knock-out mice have neuroprotective effects against focal cerebral ischemia. Neuroscience 2010; 171: 258-267.
127. Lalancette-Hebert M, Phaneuf D, Soucy G, Weng YC and Kriz J. Live imaging of Toll-like receptor 2 response in cerebral ischaemia reveals a role of olfactory bulb microglia as modulators of inflammation. Brain 2009; 132: 940-954.
128. Suzuki Y, Hattori K, Hamanaka J, Murase T, Egashira Y, Mishiro K, Ishiguro M, Tsuruma K, Hirose Y, Tanaka H, Yoshimura S, Shimazawa M, Inagaki N, Nagasawa H, Iwama T and Hara H. Pharmacological inhibition of TLR4-NOX4 signal protects against neuronal death in transient focal ischemia. Sci Rep 2012; 2: 896.
129. Chen Z, Jalabi W, Shpargel KB, Farabaugh KT, Dutta R, Yin X, Kidd GJ, Bergmann CC, Stohl-man SA and Trapp BD. Lipopolysaccharide-in-duced microglial activation and neuroprotec-tion against experimental brain injury is independent of hematogenous TLR4. J Neuro-sci 2012; 32: 11706-11715.
130. Vartanian KB, Stevens SL, Marsh BJ, Williams-Karnesky R, Lessov NS and Stenzel-Poore MP. LPS preconditioning redirects TLR signaling following stroke: TRIF-IRF3 plays a seminal role in mediating tolerance to ischemic injury. J Neuroinflammation 2011; 8: 140.
131. Lu C, Liu L, Chen Y, Ha T, Kelley J, Schweitzer J, Kalbfeisch JH, Kao RL, Williams DL and Li C. TLR2 ligand induces protection against cerebral ischemia/reperfusion injury via activation of phosphoinositide 3-kinase/Akt signaling. J Immunol 2011; 187: 1458-1466.
132. Shichita T, Hasegawa E, Kimura A, Morita R, Sakaguchi R, Takada I, Sekiya T, Ooboshi H, Kitazono T, Yanagawa T, Ishii T, Takahashi H, Mori S, Nishibori M, Kuroda K, Akira S, Miyake K and Yoshimura A. Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain. Nat Med 2012; 18: 911-917.
133. Li G, Liang X and Lotze MT. HMGB1: The Central Cytokine for All Lymphoid Cells. Front Immunol 2013; 4: 68.
134. Vabulas RM, Ahmad-Nejad P, Ghose S, Kirschning CJ, Issels RD and Wagner H. HSP70 as endogenous stimulus of the Toll/interleu-kin-1 receptor signal pathway. J Biol Chem 2002; 277: 15107-15112.
135. Mitrasinovic OM, Grattan A, Robinson CC, Lapustea NB, Poon C, Ryan H, Phong C and Murphy GM Jr. Microglia overexpressing the macrophage colony-stimulating factor receptor are neuroprotective in a microglial-hippocam-pal organotypic coculture system. J Neurosci 2005; 25: 4442-4451.
136. Lalancette-Hebert M, Swarup V, Beaulieu JM, Bohacek I, Abdelhamid E, Weng YC, Sato S and Kriz J. Galectin-3 is required for resident mi-croglia activation and proliferation in response to ischemic injury. J Neurosci 2012; 32: 10383-10395.
137. McMenamin PG. Distribution and phenotype of dendritic cells and resident tissue macro-phages in the dura mater, leptomeninges, and choroid plexus of the rat brain as demonstrated in wholemount preparations. J Comp Neurol 1999; 405: 553-562.
138. Bechmann I, Priller J, Kovac A, Bontert M, Wehner T, Klett FF, Bohsung J, Stuschke M, Dirnagl U and Nitsch R. Immune surveillance of mouse brain perivascular spaces by blood-borne macrophages. Eur J Neurosci 2001; 14: 1651-1658.
139. Lassmann H, Schmied M, Vass K and Hickey WF. Bone marrow derived elements and resident microglia in brain inflammation. Glia 1993; 7: 19-24.
140. Geissmann F, Auffray C, Palframan R, Wirrig C, Ciocca A, Campisi L, Narni-Mancinelli E and Lauvau G. Blood monocytes: distinct subsets, how they relate to dendritic cells, and their possible roles in the regulation of T-cell responses. Immunol Cell Biol 2008; 86: 398-408.
141. Varvel NH, Grathwohl SA, Baumann F, Liebig C, Bosch A, Brawek B, Thal DR, Charo IF, Heppner FL, Aguzzi A, Garaschuk O, Ransohoff RM and Jucker M. Microglial repopulation model reveals a robust homeostatic process for replacing CNS myeloid cells. Proc Natl Acad Sci U S A 2012; 109: 18150-18155.
142. Candelario-Jalil E, Yang Y and Rosenberg GA. Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neu-roinflammation and cerebral ischemia. Neuro-science 2009; 158: 983-994.
143. Walker EJ and Rosenberg GA. TIMP-3 and MMP-3 contribute to delayed inflammation and hippocampal neuronal death following global ischemia. Exp Neurol 2009; 216: 122-131.
144. Gidday JM, Gasche YG, Copin JC, Shah AR, Perez RS, Shapiro SD, Chan PH and Park TS. Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia. Am J Physiol Heart Circ Physiol 2005; 289: H558-568.
145. Wang G, Guo Q, Hossain M, Fazio V, Zeynalov E, Janigro D, Mayberg MR and Namura S. Bone marrow-derived cells are the major source of MMP-9 contributing to blood-brain barrier dysfunction and infarct formation after ischemic stroke in mice. Brain Res 2009; 1294: 183-192.
146. Dawson DA, Martin D and Hallenbeck JM. Inhibition of tumor necrosis factor-alpha reduces focal cerebral ischemic injury in the spontaneously hypertensive rat. Neurosci Lett 1996; 218: 41-44.
147. Lambertsen KL, Biber K and Finsen B. Infam-matory cytokines in experimental and human stroke. J Cereb Blood Flow Metab 2012; 32: 1677-1698.
148. Fontaine V, Mohand-Said S, Hanoteau N, Fuchs C, Pfzenmaier K and Eisel U. Neurode-generative and neuroprotective effects of tumor Necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2. J Neurosci 2002; 22: RC216.
149. Iadecola C, Zhang F, Xu S, Casey R and Ross ME. Inducible nitric oxide synthase gene expression in brain following cerebral ischemia. J Cereb Blood Flow Metab 1995; 15: 378-384.
150. Loihl AK, Asensio V, Campbell IL and Murphy S. Expression of nitric oxide synthase (NOS)-2 following permanent focal ischemia and the role of nitric oxide in infarct generation in male, female and NOS-2 gene-deficient mice. Brain Res 1999; 830: 155-164.
151. Iadecola C, Zhang F, Casey R, Nagayama M and Ross ME. Delayed reduction of ischemic brain injury and neurological defcits in mice lacking the inducible nitric oxide synthase gene. J Neurosci 1997; 17: 9157-9164.
152. Iadecola C, Zhang F and Xu X. Inhibition of in-ducible nitric oxide synthase ameliorates cerebral ischemic damage. Am J Physiol 1995; 268: R286-292.
153. Pruss H, Prass K, Ghaeni L, Milosevic M, Muselmann C, Freyer D, Royl G, Reuter U, Bae-va N, Dirnagl U, Meisel A and Priller J. Inducible nitric oxide synthase does not mediate brain damage after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab 2008; 28: 526-539.
154. Hu X, Weng Z, Chu CT, Zhang L, Cao G, Gao Y, Signore A, Zhu J, Hastings T, Greenamyre JT and Chen J. Peroxiredoxin-2 protects against 6-hydroxydopamine-induced dopaminergic neurodegeneration via attenuation of the apoptosis signal-regulating kinase (ASK1) signaling cascade. J Neurosci 2011; 31: 247-261.
155. Rashidian J, Rousseaux MW, Venderova K, Qu D, Callaghan SM, Phillips M, Bland RJ, During MJ, Mao Z, Slack RS and Park DS. Essential role of cytoplasmic cdk5 and Prx2 in multiple ischemic injury models, in vivo. J Neurosci 2009; 29: 12497-12505.
156. Del Rio Hortega P and Penfeld W. Cerebral Ci-catrix: the reaction of neuroglia and microglia to brain wounds. Bulletin of the Johns Hopkins Hospital 1892; 41: 278-303.